The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Bone Cancer
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Bone Cancer Treatment Regimens
Find the right bone cancer treatment regimen with detailed instructions on selection, dosing, and administration of anti-cancer agents such as vincristine.
Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns
Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.
Bone Cancer (Fact Sheet)
This fact sheet reviews bone cancer, including its possible causes, frequency, symptoms, diagnosis, and treatment.
Cisplatin-Induced Adverse Events in Osteosarcoma Not Improved With Pantoprazole
This phase 2 study sought to determine whether concurrent pantoprazole would improve cisplatin-induced ototoxicity and nephrotoxicity in younger patients with osteosarcoma.
Defects in DNA Imprinting Affect Development and Progression of Childhood Osteosarcoma
Osteosarcoma in children may be impacted by a defect in DNA imprinting that also occurs in their biological parents. These imprinting defects may be predictive of survival outcomes.
Potential treatment option discovered for children with Ewing’s sarcoma
Combining two anti-tumor agents appears to increase the sensitivity of cancer cells to these drugs and seems to lead to more effective Ewing’s sarcoma treatment.
Patients with rare bone cancer still have low survival rates
Mesenchymal chondrosarcoma remains classified among the more deadly cancer types.
Zoledronic acid (Zometa)
This slideshow reviews zoledronic acid (Zometa), indicated for pain reduction associated with bone metastases, hypercalcemia of malignancy, and osteolytic lesions of multiple myeloma.
Next hm-slideshow in Slides
